187 related articles for article (PubMed ID: 28160565)
1. Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation.
Zhang L; Wang Y; Zhang B; Zhang H; Zhou M; Wei M; Dong Q; Xu Y; Wang Z; Gao L; Qu Y; Shi B; Zhu J; Yin Y; Chen Y; Sun L; Zhang W; Xu S; Ying G; Wang C
Oncotarget; 2017 Apr; 8(14):23033-23047. PubMed ID: 28160565
[TBL] [Abstract][Full Text] [Related]
2. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
Shang X; Lin X; Alvarez E; Manorek G; Howell SB
Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
[TBL] [Abstract][Full Text] [Related]
3. Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling.
de Souza WF; Fortunato-Miranda N; Robbs BK; de Araujo WM; de-Freitas-Junior JC; Bastos LG; Viola JP; Morgado-Díaz JA
PLoS One; 2013; 8(9):e74994. PubMed ID: 24069372
[TBL] [Abstract][Full Text] [Related]
4. Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.
Ikari A; Sato T; Watanabe R; Yamazaki Y; Sugatani J
Biochim Biophys Acta; 2012 Jun; 1823(6):1110-8. PubMed ID: 22546605
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.
Ogawa M; Kojima T; Someya M; Nomura K; Takasawa A; Murata M; Tanaka S; Saito T; Sawada N
Histochem Cell Biol; 2012 Aug; 138(2):323-38. PubMed ID: 22544349
[TBL] [Abstract][Full Text] [Related]
6. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
Shimobaba S; Taga S; Akizuki R; Hichino A; Endo S; Matsunaga T; Watanabe R; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1170-8. PubMed ID: 26919807
[TBL] [Abstract][Full Text] [Related]
7. Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.
Che J; Yue D; Zhang B; Zhang H; Huo Y; Gao L; Zhen H; Yang Y; Cao B
Int J Med Sci; 2018; 15(4):339-351. PubMed ID: 29511369
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells.
Singh AB; Harris RC
J Biol Chem; 2004 Jan; 279(5):3543-52. PubMed ID: 14593119
[TBL] [Abstract][Full Text] [Related]
9. CITED4 enhances the metastatic potential of lung adenocarcinoma.
Zhang L; Wang Y; Sha Y; Zhang B; Zhang R; Zhang H; Xu S; Wang H; Xu Y; Chen Y; Zhao X; Zhu J; Zhang Z; Wang C
Thorac Cancer; 2021 May; 12(9):1291-1302. PubMed ID: 33759374
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells.
Arai W; Konno T; Kohno T; Kodera Y; Tsujiwaki M; Shindo Y; Chiba H; Miyajima M; Sakuma Y; Watanabe A; Kojima T
Oncotarget; 2023 Mar; 14():261-275. PubMed ID: 36961882
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
Lin X; Shang X; Manorek G; Howell SB
PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
[TBL] [Abstract][Full Text] [Related]
13. Polar and charged extracellular residues conserved among barrier-forming claudins contribute to tight junction strand formation.
Piontek A; Rossa J; Protze J; Wolburg H; Hempel C; Günzel D; Krause G; Piontek J
Ann N Y Acad Sci; 2017 Jun; 1397(1):143-156. PubMed ID: 28415153
[TBL] [Abstract][Full Text] [Related]
14. Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells.
Akizuki R; Maruhashi R; Eguchi H; Kitabatake K; Tsukimoto M; Furuta T; Matsunaga T; Endo S; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):769-780. PubMed ID: 29524521
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteins in Claudin-Low Breast Cancer Cell Lines Have a Unique Expression Profile.
Yen TY; Bowen S; Yen R; Piryatinska A; Macher BA; Timpe LC
J Proteome Res; 2017 Apr; 16(4):1391-1400. PubMed ID: 28287265
[TBL] [Abstract][Full Text] [Related]
16. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
17. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
18. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.
Rangel LB; Agarwal R; D'Souza T; Pizer ES; Alò PL; Lancaster WD; Gregoire L; Schwartz DR; Cho KR; Morin PJ
Clin Cancer Res; 2003 Jul; 9(7):2567-75. PubMed ID: 12855632
[TBL] [Abstract][Full Text] [Related]
19. Claudin-3 and claudin-19 partially restore native phenotype to ARPE-19 cells via effects on tight junctions and gene expression.
Peng S; Wang SB; Singh D; Zhao PY; Davis K; Chen B; Adelman RA; Rizzolo LJ
Exp Eye Res; 2016 Oct; 151():179-89. PubMed ID: 27593915
[TBL] [Abstract][Full Text] [Related]
20. Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Yamada G; Murata M; Takasawa A; Nojima M; Mori Y; Sawada N; Takahashi H
Med Mol Morphol; 2016 Sep; 49(3):163-9. PubMed ID: 26872891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
